Gene: ECHDC2
Official Full Name: enoyl-CoA hydratase domain containing 2provided by HGNC
Gene Summary: Predicted to enable lyase activity. Predicted to be involved in fatty acid beta-oxidation. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO18079 | ECHDC2 Knockout cell line (HeLa) | Human | ECHDC2 | 1:3~1:6 | Negative | Online Inquiry |
KO18080 | ECHDC2 Knockout cell line (HCT 116) | Human | ECHDC2 | 1:2~1:4 | Negative | Online Inquiry |
KO18081 | ECHDC2 Knockout cell line (HEK293) | Human | ECHDC2 | 1:3~1:6 | Negative | Online Inquiry |
KO18082 | ECHDC2 Knockout cell line (A549) | Human | ECHDC2 | 1:3~1:4 | Negative | Online Inquiry |
ECHDC2 Gene Knockout Cell Lines are a revolutionary tool designed for researchers investigating the functional roles of the ECHDC2 gene, which is implicated in various biological processes including lipid metabolism and cellular stress responses. These cell lines feature a targeted gene knockout, achieved through advanced CRISPR/Cas9 gene-editing technology, allowing for the precise disruption of ECHDC2 expression. This creates a unique model to study the gene's contribution to cellular pathways, disease mechanisms, and potential therapeutic targets.
The mechanism behind these knockout cell lines involves the creation of frameshift mutations within the ECHDC2 gene, effectively nullifying its function. This leads to observable phenotypic changes that can be quantified and analyzed, facilitating a deeper understanding of ECHDC2's role in metabolism and disease. By providing a simplified model free from confounding factors associated with endogenous gene expression, researchers can draw more accurate conclusions regarding the gene's contributions in various contexts.
Scientifically, ECHDC2 gene knockout cell lines are crucial in biomedical research, particularly in studies focused on metabolic disorders, cancer biology, and pharmacogenomics. Their application can help elucidate disease mechanisms, identify novel drug targets, and advance the development of targeted therapeutics.
What sets our ECHDC2 gene knockout cell lines apart from traditional models is their reliability and reproducibility. Each line is rigorously validated to ensure consistent knockout performance, thus enhancing experimental fidelity. Unlike alternatives that may be burdened by residual heterogeneity, our cell lines offer a homogenous population that streamlines experimental design and streamlined data analysis.
For researchers and clinicians alike, the ability to study the ECHDC2 gene in a controlled, knockout context opens up vast possibilities for discovery and application. Our cell lines provide unparalleled insight into gene function and hold promise for advancing personalized medicine strategies.
At [Your Company Name], we pride ourselves on delivering high-quality biological products backed by cutting-edge research and rigorous validation protocols. Our expertise in gene editing and commitment to supporting scientific discovery make our ECHDC2 gene knockout cell lines an invaluable resource for advancing your research initiatives.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.